ODAIA’s new Voice Assistant empowers biopharma sales representatives to access AI-driven insights instantly via voice commands on mobile devices.

BOSTON, Nov. 20, 2024 — ODAIA today unveiled a voice AI assistant designed for biopharma sales teams. This tool allows representatives to access real-time, AI-powered insights simply by speaking to their mobile device. Representatives can now efficiently locate healthcare professional (HCP) data on the go, improve pre-call planning, and receive personalized recommendations for future physician interactions—all through voice commands, eliminating the need for typing or clicking.

Sales representatives often use multiple tools to gather insights, including CRM systems for engagement history, dashboards for prescription and patient data, and business intelligence platforms for market analysis. This fragmented process slows down field operations. While some companies utilize AI chatbots with their raw data to find information, these tools frequently provide inaccurate, incomplete, and unreliable insights that hinder practical application.

ODAIA addresses these issues with voice AI that transcends raw data. ODAIA’s sophisticated AI engines generate intelligence on HCP and patient behavior shifts, untapped market trends and opportunities, and sales team performance. Large language models (LLMs) then translate these insights into clear, actionable information that sales representatives can easily understand and access quickly with the Voice Assistant.

“Voice-first technology will become the standard in life sciences”, said Philip Poulidis, CEO at ODAIA. “The true value of voice AI lies in its ability to tap into intelligence, not just raw data. With ODAIA Voice Assistant, we’re not only addressing current commercial team challenges but laying the groundwork for future voice-first interfaces that will transform how sales representatives interact with data, make decisions, and deliver meaningful outcomes for providers and patients.”

Speaking is three times faster than typing and more accurate.¹ However, most generic AI chatbots and standard GenAI tools often slow users down and frustrate them due to the technology’s struggles with raw data interpretation and its requirement for precise phrasing and repeated corrections. Voice Assistant overcomes this by using voice AI technology specifically built for biopharma, delivering precise and relevant insights through natural conversations.

Voice Assistant is powered by MAPTUAL, ODAIA’s proprietary platform of AI engines specifically designed for the biopharma industry. MAPTUAL uses a modular approach to analyze complex datasets and provide real-time insights into a physician’s changing behaviors, prescribing trends, and potential brand impact. Voice Assistant leverages these insights and employs GenAI to go beyond superficial responses and dynamically adapt during conversations, offering personalized, relevant guidance that enhances HCP engagement.

ODAIA Voice Assistant is anticipated to be available to early adopters in the second quarter of 2025. To learn how to participate in the early adopter program, visit: .

Also, witness how ODAIA Voice Assistant will facilitate the biopharma industry’s transition to voice AI at our Innovation Theater Session during on Nov. 21 at 10:00 a.m. CET. CEO Philip Poulidis will demonstrate how to plan daily schedules, personalize interactions with HCPs, and make data-driven decisions using ODAIA integrated with Veeva Vault CRM. To schedule a meeting with ODAIA, .

About ODAIA
ODAIA is the leading AI company assisting life sciences organizations in innovating their commercial strategies using Customer Science. The company’s cloud-based solution, MAPTUAL, integrates data science, behavioral science, and AI to gain a comprehensive understanding of healthcare professionals (HCPs) and their patient decisions throughout the customer journey. To learn more about ODAIA, visit our or follow us on .

¹

SOURCE ODAIA